Oncgnostics GmbH - Company Review
Oncgnostics GmbH - Company ReviewSummary
Oncgnostics GmbH (Oncgnostics) is an in-vitro diagnostic company that specializes in the development of in-vitro diagnostic tests for the therapeutics area of cancer. The company’s pipeline offers GynTect technology, a system based on the detection of epigenetic biomarkers, mainly in the methylation of specific DNA regions. Its GynTect allows a fast and reliable detection of cervical precancerous lesions and cancer. The company’s pipeline focuses on applications in the fields that include ovarian cancer and head-and-neck tumors. It also specializes in the IVD test development field at, after test validation and initial preclinical trials, and others. Oncgnostics is headquartered in Jena, Germany.
This comprehensive company report of Oncgnostics GmbH provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.